The kinase Mirk/dyrk1B is activated by oncogenic K-ras in pancreatic cancer cells and mediates their survival [11], at least in part, through lowering ROS levels by increasing transcription of at least three antioxidant genes. Here, KRAS is linked to pancreatic neoplasm.